Results 11 to 20 of about 1,528,999 (362)

Interstitial lung disease [PDF]

European Respiratory Review, 2014
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. Knowledge achieved in recent years has resulted in the publication of the new classification of idiopathic interstitial pneumonias, according to which there are three groups: major, rare and unclassified.
Ulrich Costabel, Ulrich Costabel, Francesco Bonella, Francesco Bonella, Katerina M. Antoniou, Venerino Poletti, Venerino Poletti, George A. Margaritopoulos, George A. Margaritopoulos, S. Tomassetti, S. Tomassetti   +10 more
openaire   +4 more sources

Intrapericardial recombinant tissue plasminogen activator in purulent pericarditis- case series

BMC Cardiovascular Disorders, 2020
Background Pericardial constriction is one of the complications of purulent pericarditis (PP). Most difficult to treat, which may develop both in early and in the late period of the disease, resulting in a very poor prognosis.
Małgorzata Dybowska, Monika Szturmowicz, Lucyna Opoka, Piotr Rudziński, Witold Tomkowski   +4 more
doaj   +1 more source

Nontuberculous Mycobacterial Lung Disease in the Patients with Cystic Fibrosis—A Challenging Diagnostic Problem

Diagnostics, 2022
Background: Cystic fibrosis (CF) is an autosomal, recessive genetic disorder, caused by a mutation in the cystic fibrosis transmembrane conductance receptor regulator (CFTR) gene.
Dorota Wyrostkiewicz, Lucyna Opoka, Dorota Filipczak, Ewa Jankowska, Wojciech Skorupa, Ewa Augustynowicz-Kopeć, Monika Szturmowicz   +6 more
doaj   +1 more source

Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis—Retrospective Cohort Analysis

Diagnostics, 2022
Hypersensitivity pneumonitis (HP) is one of the interstitial lung diseases with clearly established diagnostic criteria. Nevertheless, pharmacologic treatment recommendations are still lacking. Most specialists use steroids as first-line drugs, sometimes
Katarzyna B. Lewandowska, Inga Barańska, Małgorzata Sobiecka, Piotr Radwan-Rohrenschef, Małgorzata Dybowska, Monika Franczuk, Adriana Roży, Agnieszka Skoczylas, Iwona Bestry, Jan Kuś, Witold Z. Tomkowski, Monika Szturmowicz   +11 more
doaj   +1 more source

Tuberculous Pericarditis—Own Experiences and Recent Recommendations

Diagnostics, 2022
Tuberculous pericarditis (TBP) accounts for 1% of all forms of tuberculosis and for 1–2% of extrapulmonary tuberculosis. In endemic regions, TBP accounts for 50–90% of effusive pericarditis; in non-endemic, it only accounts for 4%.
Małgorzata Dybowska, Katarzyna Błasińska, Juliusz Gątarek, Magdalena Klatt, Ewa Augustynowicz-Kopeć, Witold Tomkowski, Monika Szturmowicz   +6 more
doaj   +1 more source

Bullous Lung Disease [PDF]

Western Journal of Emergency Medicine, 2013
[West J Emerg Med. 2013;14(5):450–451.]
Goldberg, Corey, Carey, Kathleen E
openaire   +6 more sources

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy

Diagnostics, 2023
The prevalence of pulmonary hypertension (PH) complicating interstitial lung diseases (ILDs) is 3.5–15% at an early stage, and up to 90% in ILD patients listed for lung transplantation.
Aneta Kacprzak, Witold Tomkowski, Monika Szturmowicz   +2 more
doaj   +1 more source

Phenotypes of Sarcoidosis-Associated Pulmonary Hypertension—A Challenging Mystery

Diagnostics, 2023
Sarcoidosis has been a well-recognised risk factor for pulmonary hypertension (PH) for a long time, but still, the knowledge about this concatenation is incomplete.
Aneta Kacprzak, Witold Tomkowski, Monika Szturmowicz   +2 more
doaj   +1 more source

Lung transplantation for interstitial lung disease [PDF]

European Respiratory Review, 2021
Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD.
Siddhartha G. Kapnadak, Ganesh Raghu
openaire   +3 more sources

Proceedings: Regenerative Medicine for Lung Diseases: A CIRM Workshop Report. [PDF]

, 2017
The mission of the California Institute of Regenerative Medicine (CIRM) is to accelerate treatments to patients with unmet medical needs. In September 2016, CIRM sponsored a workshop held at the University of California, Los Angeles, to discuss ...
DeWitt, Natalie D, Gomperts, Brigitte, Kadyk, Lisa C   +2 more
core   +1 more source